New blood-pressure lowering device being used in clinical trial comprising four US healthcare institutions
Editor's Note The Smidt Heart Institute at Cedars-Sinai has introduced a pioneering device aimed at treating patients with difficult-to-manage hypertension, making it one of four institutions in the US and the first on the West Coast to make use of this technology, a March 8 press release published by Cedars…
Bedside portable device offers real-time monitoring for pancreatic fistulas, other conditions
Editor's Note Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the University Hospital Dresden (UKD) have developed a portable, droplet-based millifluidic device that can monitor patients for postoperative pancreatic fistula in the critical first days after surgery. The same technology might also be expanded to analyze other body fluids and diseases.…
LivaNova receives FDA 510(k) approval for new in-line blood monitor
Editor's Note The Essenz™ In-Line Blood Monitor (ILBM) has received U.S. FDA 510(k) clearance and CE mark, as announced by manufacturer LivaNova on August 30. The new ILBM provides “accurate and continuous measurement of essential blood parameters for perfusionists throughout cardiopulmonary bypass procedures,” and integrates with the company’s Essenz Perfusion…
Free Daily News
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity